Discovery of potent and selective inhibitors of 11β-HSD1 for the treatment of metabolic syndrome
Authors:
- Steven RichardsSRSteven Richards
- Bryan SorensenBSBryan Sorensen
- Hwan-Soo JaeHJHwan-Soo Jae
- Marty WinnMWMarty Winn
- Yixian ChenYCYixian Chen
- Jiahong WangJWJiahong Wang
- Steven FungSFSteven Fung
- Katina MonzonKMKatina Monzon
- Ernst U. FrevertEFErnst U. Frevert
- Peer JacobsonPJPeer Jacobson
- Hing ShamHSHing Sham
- J.T. LinkJLJ.T. Link
- 1 December 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (24) , 6241-6245
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- 11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in miceJournal of Experimental Medicine, 2005
- 11β-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memoryTrends in Endocrinology & Metabolism, 2004
- Effects of the 11β-Hydroxysteroid Dehydrogenase Inhibitor Carbenoxolone on Insulin Sensitivity in Men with Type 2 DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2003
- Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic miceDiabetologia, 2002
- A Transgenic Model of Visceral Obesity and the Metabolic SyndromeScience, 2001
- Reduction ofN-Acyl-2,3-dihydro-4-pyridones toN-Acyl-4-piperidones Using Zinc/Acetic AcidThe Journal of Organic Chemistry, 2001
- Piperazine Imidazo[1,5-a]quinoxaline Ureas as High-Affinity GABAALigands of Dual FunctionalityJournal of Medicinal Chemistry, 1999
- 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stressProceedings of the National Academy of Sciences, 1997
- A highly stereocontrolled, four-step synthesis of (.+-.)-lasubine IIJournal of the American Chemical Society, 1988